Table: begin end state 1 19 non-cytoplasmic 20 38 transmembrane 39 64 cytoplasmic 65 90 transmembrane 91 95 non-cytoplasmic 96 120 transmembrane 121 144 cytoplasmic 145 164 transmembrane 165 191 non-cytoplasmic 192 213 transmembrane 214 223 cytoplasmic 224 245 transmembrane 246 250 non-cytoplasmic 251 275 transmembrane 276 314 cytoplasmic 315 336 transmembrane 337 359 non-cytoplasmic 360 381 transmembrane 382 395 cytoplasmic 396 419 transmembrane 420 424 non-cytoplasmic 425 445 transmembrane 446 481 cytoplasmic
Input: >WP_004311272.1 NCBI__GCF_000310185.1:WP_004311272.1 MEAFANQVVDLLNGLLWGKILIWLLVGTGIYFTLRLGFIQLRHFGHTFTVLRGSRQSDAS GISSFQALCTSLAARVGTGNIAGVAVAITLGGPGAIFWMWVIALVGMATGFAEATLAQLF KQRDDKGQFRGGPAYYMEKGLGQRWAGTMFSIFLIIAFGFAFNSVQSNTIAGAMVGAFEL DMGSFTLGGNEVAVAALVVGVAVTVLTAVIIFGGLRSIARFSELAVPFMAVGYLVVAVGI LLVNLGEVPGVLAMIVKSAFGFHEAAAGGIGAAILNGFKRGLFSNEAGMGSAPNAAAAAT PYPPHPASQGYVQMAGVFIDTILICTASAAIILLAGPVEGTGVGLVQNALTSEVGGWGKY FLAVVVLFFAFTSIVANYFYAENCLVFIEHNHPAGLLIFRLIVLAMVMFGAIGSLPFVWN FADVAMGLMAITNLVAILLLSGLVVKLAKDYNAQRAAGKLPTFDARAYPEIRSKLTPGIW D
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server